Komori
Perseus Proteomics (4882) · InitiativeRestated

Establishment of a Remuneration Committee with a Majority of Independent Outside Directors

First written in FY2022. 1 of 3 entries say "Advanced", first in FY2023. Latest entry: FY2025.

3entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2022AdvancedFY20232022: 120222023: 120232024: 020242025: 12025
Same theme, other companies
Operation of the Nomination and Compensation Committee Centered on Independent Outside DirectorsA theme 192 companies write about · 0 as a headwind · 192 as a tailwind

The whole theme swung hardest in 2025: 9 of 89 companies on the "Worse" side.

87 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 192 companies compared. The sentences above are computed from all 192.
Full recordFilings, disclosures and news, newest first
  1. FY2025RestatedAnnual report

    「Since April 2022, we have maintained a compensation advisory committee as a body that deliberates on the structure and levels of executive compensation and advises the Board of Directors, with the aim of further strengthening the independence, objectivity and accountability of the Board's functions relating to director compensation and other matters.」

    The advisory framework under which the compensation committee advises the Board of Directors to enhance independence, objectivity and accountability has been reconfirmed.
  2. FY2023AdvancedAnnual report

    「On 20 April 2022, we newly established a voluntary compensation committee, with a majority of its members being independent outside directors, to report and make recommendations to the Board of Directors. Subsequently, the voluntary compensation committee meeting held on 20 May 2022 recommended granting non-monetary compensation and other benefits to directors, and the revision of the policy for determining compensation was approved at the Board of Directors meeting held on 23 May 2022.」

    Following establishment of the compensation committee with a majority of independent outside directors, the process advanced from recommendations on non-monetary compensation to revision of the compensation policy by the Board of Directors.
  3. FY2022First statedAnnual report

    「However, to further strengthen the independence, objectivity and accountability of the Board of Directors' functions relating to director compensation and other matters, on 20 April 2022 we established a compensation committee that reports and makes recommendations to the Board of Directors and has a majority of independent outside directors among its members.」

    A compensation committee with a majority of independent outside directors was established to enhance the independence, objectivity and accountability of director compensation.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Perseus Proteomics yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.